Skip to main content
. 2020 Jul 20;2020(7):CD013006. doi: 10.1002/14651858.CD013006.pub2

NCT00203450.

Methods Randomised controlled trial
Participants Individuals who have a body mass index (BMI) > 25 and are on a psychotropic medication with a known side effect of weight gain
Interventions
  • Drug: Zonegran

  • Drug: placebo

Outcomes Primary outcome: comparison of the efficacy of zonisamide (Zonegran; 100 mg to 400 mg/d) vs placebo as an adjunctive agent for lowering weight
Notes No results available